Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels?: The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA)
about
Transitions in Metabolic Risk and Long-Term Cardiovascular Health: Coronary Artery Risk Development in Young Adults (CARDIA) Study.Psychological Well-being's Link with Cardiovascular Health in Older Adults.Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.Cardiovascular Health and Incident Hypertension in Blacks: JHS (The Jackson Heart Study).Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.Cumulative Exposure to Systolic Blood Pressure During Young Adulthood Through Midlife and the Urine Albumin-to-Creatinine Ratio at Midlife.The Case for Low Blood Pressure Targets.Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of CarThe Unchartered Frontier: Preventive Cardiology Between the Ages of 15 and 35 Years.Method of Blood Pressure Measurement, Interpretation of SPRINT, and the Atlantic Divide.Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment.A Novel Approach for Estimating Cost-Effectiveness of Pharmacological Treatment in Drug Naïve Adults with Hypertension.Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association.Longitudinal blood pressure changes and kidney function decline in persons without chronic kidney disease: Findings from the MESA study.Investing in our future: The importance of ambulatory visits to achieving blood pressure control in young adults.Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of CarCardiovascular medication changes over 5 years in a national data linkage study: implications for risk prediction models.Changes in Blood Pressure During Young Adulthood and Subsequent Kidney Function Decline: Findings From the Coronary Artery Risk Development in Young Adulthood (CARDIA) Study.Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention.White matter microstructure, white matter lesions, and hypertension: An examination of early surrogate markers of vascular-related brain change in midlife.
P2860
Q37434676-A00CF0D9-0B8D-4930-9F0A-C65C940B54FDQ38606840-D944C200-6FC5-4313-AC43-7998A8D8E10AQ38675560-2D59FD4E-D07E-41BD-A388-7EF409C5F4E8Q38707980-4A97C128-1BFF-4CEA-895C-5FEB2B1759E2Q38716505-78E4E0BB-FB50-4BDF-80EC-556798B0B1E7Q38879739-513BB717-2AEF-4B9A-9611-F4B239303BB8Q38940109-5CDA1B03-588A-48B3-B2C2-E4DF1EE62AC6Q38999152-7F05B1E5-71A5-49C2-890B-9B1B5CF584C8Q39132747-0B405A34-AAA5-41EB-A556-38154F29350EQ39167506-D3E01E1B-6A85-42D8-A8CB-358844B552C9Q39413753-C2A58D46-F372-4406-AD4E-04A9FF14300FQ41629813-94CAF129-87F9-47D3-BF80-20FE454FB5B4Q42640990-8C3A64D4-9CB9-4F4A-9EFC-51D0A65B7A31Q46019200-0664ED08-9D16-4B21-8917-217EC1213C8CQ47932287-87BA9A60-113F-4A3B-A57D-68BAE088276EQ48939835-FB064104-1E32-4DC7-BB23-CD652AC26CA4Q49387297-C1938C96-2139-4B2A-908D-1FCF2DEF0E58Q52671258-547C2B1D-BD4F-49C7-9BFE-525D6B6D3B70Q54869175-134B2ABF-6EEB-4618-BE3A-7DB574840DCEQ55002724-5D2094B8-0A8A-4F20-AC3E-91B60ED67FAC
P2860
Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels?: The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA)
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Can Antihypertensive Treatment ...... tudy of Atherosclerosis (MESA)
@ast
Can Antihypertensive Treatment ...... tudy of Atherosclerosis (MESA)
@en
type
label
Can Antihypertensive Treatment ...... tudy of Atherosclerosis (MESA)
@ast
Can Antihypertensive Treatment ...... tudy of Atherosclerosis (MESA)
@en
prefLabel
Can Antihypertensive Treatment ...... tudy of Atherosclerosis (MESA)
@ast
Can Antihypertensive Treatment ...... tudy of Atherosclerosis (MESA)
@en
P2093
P2860
P50
P356
P1476
Can Antihypertensive Treatment ...... tudy of Atherosclerosis (MESA)
@en
P2093
Christopher T Sibley
David C Goff
Gregory L Burke
Laura A Colangelo
Mark Pletcher
Pamela J Schreiner
Wendy S Post
P2860
P304
P356
10.1161/JAHA.115.002275
P577
2015-09-21T00:00:00Z